VALFIX Medical Inc. Appoints Surindra N. Mitruka, MD, MBA, as New Board Member
By: Valfix medical Inc.
"We are thrilled to welcome Dr. Mitruka to VALFIX's board of directors," said Eli Bar, CEO and Chairman of the board. "His expertise and insights will be invaluable as we continue to advance our mission to transform open heart valve surgery technique into a transcatheter procedure."
Dr. Mitruka has practiced adult cardiac, thoracic, and vascular surgery in the private sector, serving as the Director of three surgical programs and Heart Institutes in California. He has specialized in complex coronary revascularizations and minimally invasive valve surgery, and is widely published in his field. In addition, he has traveled extensively to lecture and demonstrate procedures for arrhythmia surgery and served as a KOL for Medtronic. Previously, he co-founded a medical device company that achieved a successful exit.
Since retiring from clinical medicine, Dr. Mitruka has focused on consulting and advising, as well as entrepreneurial and leadership roles in the healthcare industry. "I am excited and honored to join VALFIX's board of directors," he stated. "As a cardiac surgeon, I am extremely impressed with VALFIX technology and its potential to revolutionize the industry. I look forward to contributing to the company's growth and success."
With the appointment of Dr. Mitruka, VALFIX's board of directors now comprises six members, each with a unique set of skills and experience that will help guide the company to new heights.
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative technology offers a viable alternative to open heart surgery. To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at email@example.com